Skip to content
OpenCapital
Get started

Sabra Healthcare SBRA Equity Method Investments

Equity Method Investments at other companies

American Healthcare REIT logo
American Healthcare REITAHR
$4.42M-63.4%
Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
$507.72M+472%
Healthpeak Properties logo
Healthpeak PropertiesDOC
$530.35M-44.3%
PACS Group logo
PACS GroupPACS
$29.82M-16.2%
American Homes 4 Rent logo
American Homes 4 RentAMH
$150.71M-6.3%
Mid-America Apartment Communities logo
Mid-America Apartment CommunitiesMAA
$41.58M-0.5%

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's equity method investments?
Sabra Healthcare (SBRA) reported equity method investments of $116.54M in Q1 2026.
How has Sabra Healthcare's equity method investments changed year-over-year?
Sabra Healthcare's equity method investments decreased by 3.6% year-over-year, from $120.84M to $116.54M.
What is the long-term trend for Sabra Healthcare's equity method investments?
Over 5 years (2020 to 2025), Sabra Healthcare's equity method investments has grown at a -16.4% compound annual growth rate (CAGR), from $288.76M to $118.17M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.